ERCC2 and neoplasm: Kim et al [21] have previously examined the mutational processes in urothelial cancer, a cancer in which the NER gene ERCC2 is significantly mutated, and proposed that such tumor cohorts demonstrate a strong association between somatic ERCC2 mutations and mutational signature 5.